Inhibition of RANTES/CCR1-mediated chemotaxis by cosalane and related compounds

Bioorg Med Chem Lett. 2001 Jan 8;11(1):59-62. doi: 10.1016/s0960-894x(00)00601-6.

Abstract

The anti-HIV agent cosalane and several of its analogues inhibited RANTES-induced migration of human monocytes, but they did not inhibit migration induced by MIP1alpha or MIP1beta. RANTES-induced migration of single receptor CCRI-HEK transfectants was also inhibited by the cosalanes. Acetylation of the reactive amino groups of RANTES abrogated the inhibitory activity of cosalane. The data suggest that cosalane and its structural analogues may interfere with the RANTES/CCR1 interaction by binding to RANTES.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylation
  • Anti-HIV Agents / chemical synthesis
  • Anti-HIV Agents / chemistry*
  • Anti-HIV Agents / metabolism
  • Anti-HIV Agents / pharmacology*
  • Aurintricarboxylic Acid / analogs & derivatives
  • Aurintricarboxylic Acid / chemistry
  • Aurintricarboxylic Acid / metabolism
  • Aurintricarboxylic Acid / pharmacology*
  • Cell Line
  • Chemokine CCL5 / antagonists & inhibitors*
  • Chemokine CCL5 / chemistry
  • Chemokine CCL5 / metabolism
  • Chemokine CCL5 / pharmacology
  • Chemokine CXCL12
  • Chemokines, CXC / pharmacology
  • Chemotaxis / drug effects*
  • Humans
  • Lymphocytes / drug effects
  • Molecular Structure
  • Protein Binding
  • Receptors, CCR1
  • Receptors, Chemokine / antagonists & inhibitors*
  • Receptors, Chemokine / metabolism
  • Transfection

Substances

  • Anti-HIV Agents
  • CCR1 protein, human
  • CXCL12 protein, human
  • Chemokine CCL5
  • Chemokine CXCL12
  • Chemokines, CXC
  • Receptors, CCR1
  • Receptors, Chemokine
  • cosalane
  • Aurintricarboxylic Acid